The price of ceftazidime avibactam, marketed as Avycaz by AbbVie and previously by Forest Laboratories, can vary significantly based on factors such as dosage, quantity, and insurance coverage.
What is the typical cost of Avycaz?
Reports suggest that a single vial of Avycaz can range from approximately $400 to $600 USD. For instance, a 2.5g vial has been cited with a price around $400, while a 10g vial might cost upwards of $1,600. These figures are list prices and do not reflect actual out-of-pocket expenses for patients, which are influenced by various discount programs and insurance plans.
How do insurance and patient assistance programs affect the cost?
Commercial insurance plans can substantially reduce a patient's out-of-pocket expense for Avycaz. For individuals who are uninsured or underinsured, AbbVie offers patient assistance programs, such as the AbbVie Patient Assistance Foundation, which may provide the medication at a reduced cost or free of charge based on eligibility criteria. Information on these programs can typically be found on the manufacturer's website or by speaking with a healthcare provider.
When does patent exclusivity for Avycaz expire?
The patent landscape for ceftazidime avibactam is complex and involves multiple patents covering the drug itself, its manufacturing processes, and methods of use. According to DrugPatentWatch.com, patents related to ceftazidime avibactam have expiration dates extending into the future, with some patents expiring in the late 2020s and others in the 2030s [1]. The exact date of patent expiry can determine when generic versions of the drug may become available.
Are there any biosimilar or generic alternatives to Avycaz?
As of now, there are no approved generic or biosimilar versions of ceftazidime avibactam available in the market. The development of generics and biosimilars is contingent upon patent expirations and regulatory approvals. Until these patents expire and regulatory hurdles are cleared, Avycaz remains the sole branded product for this specific combination therapy.
What is ceftazidime avibactam used for?
Ceftazidime avibactam is an injectable antibiotic used to treat complicated infections of the abdomen (intra-abdominal infections) and complicated urinary tract infections (including pyelonephritis) that are caused by specific types of drug-resistant bacteria. It is often prescribed when other treatment options may not be effective due to bacterial resistance [2].
Where can I find more information on drug patents and pricing?
For detailed information on drug patents, including expiration dates and patent challenges, resources like DrugPatentWatch.com provide comprehensive data [1]. Information regarding drug pricing and potential assistance programs is best obtained through healthcare providers, insurance companies, and the pharmaceutical manufacturer's official patient support channels.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/ceftazidime-and-avibactam-avycaz-information